Literature DB >> 14581545

Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection.

Chloe L Thio1, David L Thomas, Peter Karacki, Xiaojiang Gao, Darlene Marti, Richard A Kaslow, James J Goedert, Margaret Hilgartner, Steffanie A Strathdee, Priya Duggal, Stephen J O'Brien, Jacquie Astemborski, Mary Carrington.   

Abstract

Following an acute hepatitis B virus (HBV) infection, clearance or persistence is determined in part by the vigor and breadth of the host immune response. Since the human leukocyte antigen system (HLA) is an integral component of the immune response, we hypothesized that the highly polymorphic HLA genes are key determinants of viral clearance. HLA class I and II genes were molecularly typed in 194 Caucasian individuals with viral persistence and 342 matched controls who had cleared the virus. A single class I allele, A*0301 (odds ratio [OR], 0.47; 95% confidence interval [CI], 0.30 to 0.72; P = 0.0005) was associated with viral clearance. The class II allele DRB1*1302 was also associated with clearance (OR, 0.42; 95% CI, 0.19 to 0.93; P = 0.03), but its significance decreased in a multivariate model that included other alleles associated with disease outcome as covariates. B*08 was associated with viral persistence both independently (OR, 1.59; 95% CI, 1.04 to 2.43; P = 0.03) and as part of the conserved Caucasian haplotype A*01-B*08-DRB1*03. The B*44-Cw*1601 (OR, 2.23; 95% CI, 1.13 to 4.42; P = 0.02) and B*44-Cw*0501 (OR, 1.99; 95% CI, 1.22 to 3.24; P = 0.006) haplotypes were also associated with viral persistence. Interestingly, both the B*08 haplotype and DR7, which forms a haplotype with B*44-Cw*1601, have been associated with nonresponse to the HBV vaccine. The associations with class I alleles are consistent with a previously implicated role for CD8-mediated cytolytic-T-cell response in determining the outcome of an acute HBV infection.

Entities:  

Mesh:

Year:  2003        PMID: 14581545      PMCID: PMC254245          DOI: 10.1128/jvi.77.22.12083-12087.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Genetic prediction of nonresponse to hepatitis B vaccine.

Authors:  C A Alper; M S Kruskall; D Marcus-Bagley; D E Craven; A J Katz; S J Brink; J L Dienstag; Z Awdeh; E J Yunis
Journal:  N Engl J Med       Date:  1989-09-14       Impact factor: 91.245

2.  The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants.

Authors:  D Vlahov; J C Anthony; A Munoz; J Margolick; K E Nelson; D D Celentano; L Solomon; B F Polk
Journal:  NIDA Res Monogr       Date:  1991

3.  CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection.

Authors:  Robert Thimme; Stefan Wieland; Carola Steiger; John Ghrayeb; Keith A Reimann; Robert H Purcell; Francis V Chisari
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

4.  A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia.

Authors:  J J Goedert; C M Kessler; L M Aledort; R J Biggar; W A Andes; G C White; J E Drummond; K Vaidya; D L Mann; M E Eyster
Journal:  N Engl J Med       Date:  1989-10-26       Impact factor: 91.245

5.  Typing of HLA-DQA1 and DQB1 using DNA single-strand conformation polymorphism.

Authors:  M Carrington; T Miller; M White; B Gerrard; C Stewart; M Dean; D Mann
Journal:  Hum Immunol       Date:  1992-03       Impact factor: 2.850

6.  Hemophilia growth and development study. Design, methods, and entry data.

Authors:  M W Hilgartner; S M Donfield; A Willoughby; C F Contant; B L Evatt; E D Gomperts; W K Hoots; J Jason; K A Loveland; S M McKinlay
Journal:  Am J Pediatr Hematol Oncol       Date:  1993-05

7.  The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants.

Authors:  R A Kaslow; D G Ostrow; R Detels; J P Phair; B F Polk; C R Rinaldo
Journal:  Am J Epidemiol       Date:  1987-08       Impact factor: 4.897

8.  Hepatitis B virus markers in Chinese twins.

Authors:  T M Lin; C J Chen; M M Wu; C S Yang; J S Chen; C C Lin; T Y Kwang; S T Hsu; S Y Lin; L C Hsu
Journal:  Anticancer Res       Date:  1989 May-Jun       Impact factor: 2.480

9.  Hepatitis and Australia antigen: autosomal recessive inheritance of susceptibility to infection in humans.

Authors:  B S Blumberg; J S Friedlaender; A Woodside; A I Sutnick; W T London
Journal:  Proc Natl Acad Sci U S A       Date:  1969-04       Impact factor: 11.205

10.  The immune response to hepatitis B vaccine in humans: inheritance patterns in families.

Authors:  M S Kruskall; C A Alper; Z Awdeh; E J Yunis; D Marcus-Bagley
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

View more
  52 in total

1.  Polymorphisms of microsomal triglyceride transfer protein in different hepatitis B virus-infected patients.

Authors:  Zhi-Tao Yang; Xin-Xin Zhang; Xiao-Fei Kong; Dong-Hua Zhang; Shen-Ying Zhang; Jie-Hong Jiang; Qi-Ming Gong; Gen-Di Jin; Zhi-Meng Lu
Journal:  World J Gastroenterol       Date:  2008-09-21       Impact factor: 5.742

2.  Analysis of the CD8+ T cell anti-HIV activity in heterologous cell co-cultures reveals the benefit of multiple HLA class I matches.

Authors:  M Scott Killian; Fernando Teque; Ramu Sudhagoni
Journal:  Immunogenetics       Date:  2017-07-22       Impact factor: 2.846

3.  Polymorphism in intron 1 of the interferon-gamma gene influences both serum immunoglobulin E levels and the risk for chronic hepatitis B virus infection in Polynesians.

Authors:  William Abbott; Edward Gane; Ingrid Winship; Stephen Munn; Colin Tukuitonga
Journal:  Immunogenetics       Date:  2007-01-09       Impact factor: 2.846

4.  Host susceptibility to persistent hepatitis B virus infection.

Authors:  Ying-Li He; Ying-Ren Zhao; Shu-Lin Zhang; Shu-Mei Lin
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

5.  Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype.

Authors:  Cornelia L Trimble; Steven Piantadosi; Patti Gravitt; Brigitte Ronnett; Ellen Pizer; Andrea Elko; Barbara Wilgus; William Yutzy; Richard Daniel; Keerti Shah; Shiwen Peng; Chienfu Hung; Richard Roden; Tzyy Choou Wu; Drew Pardoll
Journal:  Clin Cancer Res       Date:  2005-07-01       Impact factor: 12.531

6.  Hepatitis B infection outcome is associated with novel human leukocyte antigen variants in Ghanaian cohort.

Authors:  Kwesi Z Tandoh; Kwadwo A Kusi; Timothy N Archampong; Isaac Boamah; Osbourne Quaye
Journal:  Exp Biol Med (Maywood)       Date:  2020-04-29

7.  Genetic protection against hepatitis B virus conferred by CCR5Delta32: Evidence that CCR5 contributes to viral persistence.

Authors:  Chloe L Thio; Jacquie Astemborski; Arman Bashirova; Timothy Mosbruger; Spencer Greer; Mallory D Witt; James J Goedert; Margaret Hilgartner; Audrey Majeske; Stephen J O'Brien; David L Thomas; Mary Carrington
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

8.  Clear and independent associations of several HLA-DRB1 alleles with differential antibody responses to hepatitis B vaccination in youth.

Authors:  Yufeng Li; Rong Ni; Wei Song; Wenshuo Shao; Sadeep Shrestha; Sushma Ahmad; Coleen K Cunningham; Patricia M Flynn; Bill G Kapogiannis; Craig M Wilson; Jianming Tang
Journal:  Hum Genet       Date:  2009-07-14       Impact factor: 4.132

9.  Susceptible and protective HLA class 1 alleles against dengue fever and dengue hemorrhagic fever patients in a Malaysian population.

Authors:  Ramapraba Appanna; Sasheela Ponnampalavanar; Lucy Lum Chai See; Shamala Devi Sekaran
Journal:  PLoS One       Date:  2010-09-28       Impact factor: 3.240

Review 10.  A rationalized approach to the treatment of patients infected with hepatitis B.

Authors:  Natravis R Cox; Keyur Patel; Hans L Tillmann
Journal:  Mol Diagn Ther       Date:  2014-04       Impact factor: 4.074

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.